{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:56:52Z","timestamp":1792785412825,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007915","name":"Baylor College of Medicine","doi-asserted-by":"publisher","award":["NS073712"],"award-info":[{"award-number":["NS073712"]}],"id":[{"id":"10.13039\/100007915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007915","name":"Baylor College of Medicine","doi-asserted-by":"publisher","award":["AI084981"],"award-info":[{"award-number":["AI084981"]}],"id":[{"id":"10.13039\/100007915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM088129"],"award-info":[{"award-number":["GM088129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI053831"],"award-info":[{"award-number":["AI053831"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR069960"],"award-info":[{"award-number":["AR069960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL007676"],"award-info":[{"award-number":["HL007676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Robert W. Beart Endowment in Chemistry","id":[{"id":"https:\/\/ror.org\/0229evh14","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM118969"],"award-info":[{"award-number":["GM118969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM118971"],"award-info":[{"award-number":["GM118971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM118970"],"award-info":[{"award-number":["GM118970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HG006348"],"award-info":[{"award-number":["HG006348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR024574"],"award-info":[{"award-number":["RR024574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA125123"],"award-info":[{"award-number":["CA125123"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008527","name":"Dan L. Duncan Cancer Center at Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008527","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.clim.2017.03.014","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T16:09:47Z","timestamp":1491322187000},"page":"45-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog"],"prefix":"10.1016","volume":"180","author":[{"given":"Mark R.","family":"Tanner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev B.","family":"Tajhya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redwan","family":"Huq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Gehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathia E.","family":"Rodarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa A.","family":"Atik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-5874","authenticated-orcid":false,"given":"Christine","family":"Beeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.03.014_bb0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"issue":"46","key":"10.1016\/j.clim.2017.03.014_bb0010","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.clim.2017.03.014_bb0015","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1074\/jbc.M113.517037","article-title":"Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma","volume":"289","author":"Koshy","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.03.014_bb0025","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI200112516","article-title":"CD4+CD28- costimulation-independent T cells in multiple sclerosis","volume":"108","author":"Markovic-Plese","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.03.014_bb0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1172\/JCI0214114","article-title":"GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes","volume":"109","author":"Viglietta","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.03.014_bb0035","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI16921","article-title":"The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS","volume":"111","author":"Wulff","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.03.014_bb0040","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1073\/pnas.0501770102","article-title":"The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain","volume":"201","author":"Rus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.03.014_bb0045","doi-asserted-by":"crossref","first-page":"18425","DOI":"10.1073\/pnas.0508621102","article-title":"Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes","volume":"102","author":"Pinkse","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.03.014_bb0050","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/brain\/awl179","article-title":"Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients","volume":"129","author":"Rinaldi","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.clim.2017.03.014_bb0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/eji.200636656","article-title":"Generalized multi-organ autoimmunity in CCR7-deficient mice","volume":"37","author":"Davalos-Misslitz","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2017.03.014_bb0060","first-page":"640","article-title":"Potassium channels as therapeutic targets for autoimmune disorders","volume":"6","author":"Wulff","year":"2003","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.clim.2017.03.014_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2011.07.016","article-title":"Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases","volume":"59","author":"Chi","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.clim.2017.03.014_bb0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tips.2004.03.010","article-title":"K+ channels as targets for specific immunomodulation","volume":"25","author":"Chandy","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.clim.2017.03.014_bb0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/187152811797200641","article-title":"Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases","volume":"10","author":"Beeton","year":"2011","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.clim.2017.03.014_bb0080","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.104.008193","article-title":"Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases","volume":"67","author":"Beeton","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.clim.2017.03.014_bb0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1073858405278016","article-title":"Potassium channels, memory T cells, and multiple sclerosis","volume":"11","author":"Beeton","year":"2005","journal-title":"Neuroscientist"},{"issue":"24","key":"10.1016\/j.clim.2017.03.014_bb0090","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","article-title":"Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis","volume":"98","author":"Beeton","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.clim.2017.03.014_bb0095","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/jid.2013.141","article-title":"Blocking potassium channels (Kv1.3): a new treatment option for alopecia areata?","volume":"133","author":"Gilhar","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.clim.2017.03.014_bb0100","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.crohns.2014.04.003","article-title":"Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis","volume":"8","author":"Koch Hansen","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"24","key":"10.1016\/j.clim.2017.03.014_bb0105","doi-asserted-by":"crossref","first-page":"E2239","DOI":"10.1073\/pnas.1221206110","article-title":"Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance","volume":"110","author":"Upadhyay","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.clim.2017.03.014_bb0110","doi-asserted-by":"crossref","first-page":"F1258","DOI":"10.1152\/ajprenal.00374.2010","article-title":"Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis","volume":"299","author":"Hyodo","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2017.03.014_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2014.07.003","article-title":"Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis\u2014xenograft model","volume":"55","author":"Kundu-Raychaudhuri","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.03.014_bb0120","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.imbio.2016.06.004","article-title":"Calcium influx kinetics, and the features of potassium channels of peripheral lymphocytes in primary Sj\u00f6gren's syndrome","volume":"221","author":"Leg\u00e1ny","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.clim.2017.03.014_bb0125","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.immuni.2008.07.015","article-title":"Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block","volume":"29","author":"Matheu","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.03.014_bb0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.112.191890","article-title":"Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease","volume":"342","author":"Tarcha","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.clim.2017.03.014_bb0135","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4049\/jimmunol.166.2.936","article-title":"Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation","volume":"166","author":"Beeton","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.03.014_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1359\/jbmr.0301213","article-title":"Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease","volume":"19","author":"Valverde","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clim.2017.03.014_bb0145","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1096\/fj.14-251967","article-title":"Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases","volume":"28","author":"Chhabra","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2017.03.014_bb0150","unstructured":"K. Chandy, C. Beeton, and M. Pennington, Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels. (2006) Patent WO\/2006\/042151."},{"issue":"Suppl. 10","key":"10.1016\/j.clim.2017.03.014_bb0155","article-title":"Dalazatide (ShK-186), a first-in-class blocker of Kv1.3 potassium channel on effector memory T cells: safety, tolerability and proof of concept of immunomodulation in patients with active plaque psoriasis [abstract]","volume":"67","author":"Munoz-Elias","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.03.014_bb0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3280321","article-title":"A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom","volume":"328","author":"Lebrun","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2017.03.014_bb0165","doi-asserted-by":"crossref","first-page":"e4509","DOI":"10.1038\/srep04509","article-title":"A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases","volume":"4","author":"Rashid","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2017.03.014_bb0170","doi-asserted-by":"crossref","first-page":"55690","DOI":"10.1074\/jbc.M410055200","article-title":"Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins","volume":"279","author":"Regaya","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0175","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/prot.20681","article-title":"The impact of the fourth disulfide bridge in scorpion toxins of the alpha-KTx6 subfamily","volume":"61","author":"Carrega","year":"2005","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.clim.2017.03.014_bb0180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.xphs.2015.10.025","article-title":"Pulmonary delivery of the Kv1.3-blocking peptide HsTX1[R14A] for the treatment of autoimmune diseases","volume":"105","author":"Jin","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.clim.2017.03.014_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2016.05.008","article-title":"Enabling Noninvasive Systemic Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] via the Buccal Mucosa","volume":"105","author":"Jin","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.clim.2017.03.014_bb0190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.clim.2017.03.014_bb0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2017.03.014_bb0200","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1021\/acs.jmedchem.5b00495","volume":"58","author":"Murray","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0205","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1111\/bph.13347","article-title":"The concise guide to PHARMACOLOGY 2015\/16: overview","volume":"172","author":"Alexander","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.clim.2017.03.014_bb0210","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0026-895X(25)10594-4","article-title":"Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines","volume":"45","author":"Grissmer","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.clim.2017.03.014_bb0215","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1152\/ajpcell.1993.265.5.C1230","article-title":"Influence of cloned voltage-gated K+ channel expression on alanine transport, Rb+ uptake, and cell volume","volume":"265","author":"Felipe","year":"1993","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.clim.2017.03.014_bb0220","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1074\/jbc.M212868200","article-title":"A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes","volume":"278","author":"Beeton","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0225","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/j.febslet.2012.09.038","article-title":"A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3","volume":"586","author":"Pennington","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clim.2017.03.014_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078712","article-title":"A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmation","volume":"8","author":"Rashid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.03.014_bb0235","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/md13010529","article-title":"Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK","volume":"13","author":"Pennington","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.clim.2017.03.014_bb0240","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/10567","article-title":"Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses","volume":"5","author":"Fl\u00fcgel","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.03.014_bb0245","first-page":"402","article-title":"Preparing T cell growth factor from rat splenocytes","volume":"10","author":"Beeton","year":"2007","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.clim.2017.03.014_bb0250","doi-asserted-by":"crossref","first-page":"33808","DOI":"10.1038\/srep33808","article-title":"Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation","volume":"6","author":"Huq","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2017.03.014_bb0255","first-page":"266","article-title":"Drawing blood from rats through the saphenous vein and by cardiac puncture","volume":"7","author":"Beeton","year":"2007","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.clim.2017.03.014_bb0260","first-page":"e237","article-title":"Induction and monitoring of active delayed type hypersensitivity (DTH) in rats","volume":"6","author":"Beeton","year":"2007","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.clim.2017.03.014_bb0265","first-page":"325","article-title":"Induction and monitoring of adoptive delayed-type hypersensitivity in rats","volume":"8","author":"Beeton","year":"2007","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.clim.2017.03.014_bb0270","first-page":"96","article-title":"KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis. Arthritis","volume":"67","author":"Tanner","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2017.03.014_bb0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jim.2014.06.015","article-title":"PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension array","volume":"412","author":"Pochechueva","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clim.2017.03.014_bb0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ab.2011.02.009","article-title":"The importance of using the optimal plasticware and glassware in studies involving peptides","volume":"414","author":"Goebel-Stengel","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.clim.2017.03.014_bb0285","doi-asserted-by":"crossref","first-page":"e0122419","DOI":"10.1371\/journal.pone.0122419","article-title":"Adsorption of cationic peptides to solid surfaces of glass and plastic","volume":"10","author":"Kristensen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.03.014_bb0290","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/s90100645","article-title":"Reduction of non-specific protein adsorption using poly(ethylene) glycol (PEG) modified polyacrylate hydrogels in immunoassays for staphylococcal enterotoxin B detection","volume":"9","author":"Charles","year":"2009","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.clim.2017.03.014_bb0295","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/mol.108.052704","article-title":"Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes","volume":"75","author":"Pennington","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.clim.2017.03.014_bb0300","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1074\/jbc.M706008200","article-title":"The d-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation","volume":"283","author":"Beeton","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0305","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/mol.112.078006","article-title":"Vm24, a natural immunosuppressant peptide potently and selectively blocks Kv1.3 potassium channels of human T cells","volume":"82","author":"Varga","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.clim.2017.03.014_bb0310","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0002-9440(10)63416-5","article-title":"Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis","volume":"165","author":"Teuscher","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2017.03.014_bb0315","doi-asserted-by":"crossref","first-page":"22704","DOI":"10.1074\/jbc.M114.568642","article-title":"Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life","volume":"289","author":"Edwards","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0320","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.toxicon.2012.05.017","article-title":"Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria","volume":"60","author":"Chang","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.clim.2017.03.014_bb0325","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2012.03484.x","article-title":"Kv1.1 and Kv1.2: similar channels, different seizure models","volume":"53","author":"Robins","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.clim.2017.03.014_bb0330","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1523\/JNEUROSCI.5591-09.2010","article-title":"Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy","volume":"30","author":"Glasscock","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2017.03.014_bb0335","doi-asserted-by":"crossref","first-page":"C1837","DOI":"10.1152\/ajpcell.00405.2006","article-title":"Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension","volume":"292","author":"Remillard","year":"2007","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.clim.2017.03.014_bb0340","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/hmg\/ddl143","article-title":"Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation","volume":"15","author":"Olson","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.clim.2017.03.014_bb0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/jhg.2009.26","article-title":"Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation","volume":"54","author":"Yang","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.clim.2017.03.014_bb0350","doi-asserted-by":"crossref","first-page":"37137","DOI":"10.1074\/jbc.M003941200","article-title":"Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences","volume":"275","author":"Ghanshani","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0355","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/rheumatology\/kel414","article-title":"What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity","volume":"46","author":"Iikuni","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2017.03.014_bb0360","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1074\/jbc.M111.312264","article-title":"KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"287","author":"Hu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.03.014_bb0365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2017.03.014_bb0370","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-016-1003-4","article-title":"Different expression of \u03b2 subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes","volume":"18","author":"Peth\u0151","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.03.014_bb0375","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar2292","article-title":"Cells of the synovium in rheumatoid arthritis. Chondrocytes","volume":"9","author":"Otero","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.03.014_bb0380","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2110","article-title":"Cells of the synovium in rheumatoid arthritis. Osteoclasts","volume":"9","author":"Schett","year":"2007","journal-title":"Arthritis Res. Ther."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616306209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616306209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T16:40:02Z","timestamp":1750178402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616306209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":76,"alternative-id":["S1521661616306209"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.03.014","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}